Clinical Trial Update: Famotidine in Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on famotidine for schizophrenia, covering Phase 2 and Phase 3, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Famotidine (famotidine)

Snippet

Sponsor: Jesper Ekelund | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: UNKNOWN